Key result
A subcutaneous array electrode significantly lowered the mean defibrillation threshold to 14.9 J compared to a transvenous lead alone (17.5 J, P=0.0001) or with a patch (16.9 J, P=0.007).
Why the study?
Does a transvenous lead linked to a subcutaneous array electrode lower the defibrillation threshold compared to a transvenous lead alone or linked to a patch electrode in patients undergoing ICD implantation?
Population
267 patients undergoing ICD implantation, mean age 63 +/- 11 years, 82% male, mean LVEF 0.33 +/- 0.13.
Comparison
Transvenous lead linked to an investigational… vs Single transvenous lead alone or transvenous…
Design
RCT, Randomized to one of the three nonthoracotomy ICD lead systems
Authors
Loading...
Supports subcutaneous array use to lower defibrillation thresholds during ICD implantation; extends RCT evidence for nonthoracotomy lead optimization.
RCT (n=267)
randomized
Does a transvenous lead linked to a subcutaneous array electrode lower the defibrillation threshold compared to a transvenous lead alone or linked to a patch electrode in patients undergoing ICD implantation?
Absolute Event Rate: 14.9% vs 17.5%
p-value: p=0.0001
A subcutaneous array electrode linked to a transvenous lead significantly lowers the defibrillation threshold compared to a standard patch or transvenous lead alone during nonthoracotomy ICD implantation.
Baker et al. (1997) conducted an RCT in Ventricular tachycardia or fibrillation requiring ICD (n=267). Subcutaneous array electrode linked to a transvenous lead vs. Transvenous lead alone or linked to a subcutaneous/submuscular patch electrode was evaluated on Defibrillation threshold (DFT) (p=0.0001). A subcutaneous array electrode significantly lowered the mean defibrillation threshold to 14.9 J compared to a transvenous lead alone (17.5 J, P=0.0001) or with a patch (16.9 J, P=0.007).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: